Long Intergenic Non-Coding RNA 01121 Promotes Breast Cancer Cell Proliferation, Migration, and Invasion via the miR-150-5p/HMGA2 Axis
Authors Wang Z, Wang P, Cao L, Li F, Duan S, Yuan G, Xiao L, Guo L, Yin H, Xie D, Zhu J, Chen X, Zhang M
Received 9 September 2019
Accepted for publication 16 December 2019
Published 30 December 2019 Volume 2019:11 Pages 10859—10870
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Editor who approved publication: Dr Eileen O'Reilly
Zhuolu Wang,1 Pinghu Wang,1 Lin Cao,1 Fucheng Li,1 Shenjia Duan,1 Guorong Yuan,1 Lixin Xiao,1 Lin Guo,1 Hong Yin,1 Duying Xie,1 Jing Zhu,1 Xingchu Chen,1 Mengqi Zhang2
1Department of Breast Surgery, Hunan Provincial Maternal and Child Health Care Hospital, Changsha 410008, People’s Republic of China; 2Department of Neurology, Xiangya Hospital, Central South University, Changsha 410008, People’s Republic of China
Correspondence: Xingchu Chen
Department of Breast Surgery, Hunan Provincial Maternal and Child Health Care Hospital, No. 53, Xiangchun Road, Kaifu District, Changsha 410008, People’s Republic of China
Department of Neurology, Xiangya Hospital, Central South University, No. 87 Xiangya Road, Changsha 410008, People’s Republic of China
Purpose: Long intergenic noncoding RNA 01121 (LINC01121) has been reported to be aberrantly expressed and acts as an oncogene in pancreatic cancer. However, the detailed molecular mechanism of LINC01121 in breast cancer remains largely unclear. In this study, we aimed to investigate the expression and biological function of LINC01121 in breast cancer.
Methods: LINC01121 and miR-150-5p expression were measured in breast cancer cell lines using quantitative reverse transcription PCR. MTS and ﬂow cytometry assays were performed to determine cell proliferation, the cell cycle, and apoptosis. Cell migration and invasion were assessed by transwell assay. The protein expression of HMGA2 in breast cancer cell lines was measured by Western blotting. A luciferase reporter assay was used to assess the binding of LINC01121 and miR-150-5p.
Results: We found that LINC01121 was markedly up-regulated in breast cancer cell lines compared with normal breast epithelial cells. LINC01121 down-regulation markedly suppressed cell proliferation, cell cycle progression, migration, and invasion and promoted apoptosis in breast cancer cells. Further investigation showed that LINC01121 could serve as a molecular sponge for miR-150-5p and indirectly modulate the expression of its target, HMGA2. Moreover, miR-150-5p knockdown rescued the effects of LINC01121 down-regulation on HMGA2 protein expression, cell proliferation, cell cycle progression, apoptosis, migration, and invasion in breast cancer cells.
Conclusion: Knockdown LINC01121 inhibited breast cancer cell proliferation, migration, and invasion via the miR-150-5p/HMGA2 axis.
Keywords: breast cancer, LINC01121, growth, migration, invasion, miR-150-5p
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]